This study is testing a new medicine called lanifibranor for people with NASH, a liver disease. NASH stands for Non-Alcoholic Steatohepatitis, which is a liver problem that causes inflammation and damage. The study has two parts. In the first part, some people will get lanifibranor, and others will get a placebo (a pretend medicine) to see how well it works. In the second part, everyone will get the real medicine to see if it is safe to use for a longer time.

• The study lasts several months and requires regular doctor visits.
• Participants must have been diagnosed with NASH and meet certain health requirements.
• There are no costs for treatment, but participants must agree to follow study rules.

To join, you must be 18 or older, have stable weight, and meet certain health criteria. If you have other liver diseases, are pregnant, or have had certain surgeries or treatments, you may not be eligible. If you join, doctors will closely watch your health and how your body reacts to the treatment.